A mate-analysis of the effect of vitamin E supplementation on adult patients with NAFLD showed that the value of liver enzymes was reduced by vitamin E administration compared to the placebo (−5.71 IU/L, 95% CI: −9.49 to −1.93 for AST and −7.37 IU/L, 95% CI: −10.11 to −4.64 for ALT) (Vadarlis and Antza, 2021). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.